Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faming Jiang

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2009
Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applicationsLawrence Toll, Taline V Khroyan, Willma E Polgar, et al.
Cancer Biology & Therapy|July 28, 2009
A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cellsNurulain T Zaveri, Barbara G Sato, Faming Jiang, et al.
ACS Applied Materials & Interfaces|October 5, 2016
Air Cushion Convection Inhibiting Icing of Self-Cleaning SurfacesQin Yang, Zhuangzhu Luo, Faming Jiang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 30, 2006
SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in miceTaline V Khroyan, Nurulain T Zaveri, Willma E Polgar, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 2011
Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in miceTaline V Khroyan, Willma E Polgar, Juan Orduna, et al.
Journal of Medicinal Chemistry|May 28, 2004
A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptorNurulain T Zaveri, Faming Jiang, Cris M Olsen, et al.
European Journal of Pharmacology|March 17, 2009
Activity of new NOP receptor ligands in a rat peripheral mononeuropathy model: potentiation of morphine anti-allodynic activity by NOP receptor antagonistsTaline V Khroyan, Willma E Polgar, Juan Orduna, et al.
Neuropharmacology|October 8, 2013
[¹²⁵I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptorsJinhua Wu, David C Perry, James E Bupp, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 13, 2026
Impact of systemic-to-pulmonary artery shunt embolization on right heart hemodynamics in patients with bronchiectasisHongxia Wu, Faming Jiang, Li Guo, et al.
Frontiers in Cellular and Infection Microbiology|February 16, 2026
Bovine leukemia virus: an emerging concern for zoonotic cross-species transmissionChangqing Yu, Yujing Li, Haojie Wang, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2009
Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applicationsLawrence Toll, Taline V Khroyan, Willma E Polgar, et al.
Cancer Biology & Therapy|July 28, 2009
A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cellsNurulain T Zaveri, Barbara G Sato, Faming Jiang, et al.
ACS Applied Materials & Interfaces|October 5, 2016
Air Cushion Convection Inhibiting Icing of Self-Cleaning SurfacesQin Yang, Zhuangzhu Luo, Faming Jiang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 30, 2006
SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in miceTaline V Khroyan, Nurulain T Zaveri, Willma E Polgar, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 2011
Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in miceTaline V Khroyan, Willma E Polgar, Juan Orduna, et al.
Journal of Medicinal Chemistry|May 28, 2004
A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptorNurulain T Zaveri, Faming Jiang, Cris M Olsen, et al.
European Journal of Pharmacology|March 17, 2009
Activity of new NOP receptor ligands in a rat peripheral mononeuropathy model: potentiation of morphine anti-allodynic activity by NOP receptor antagonistsTaline V Khroyan, Willma E Polgar, Juan Orduna, et al.
Neuropharmacology|October 8, 2013
[¹²⁵I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptorsJinhua Wu, David C Perry, James E Bupp, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 13, 2026
Impact of systemic-to-pulmonary artery shunt embolization on right heart hemodynamics in patients with bronchiectasisHongxia Wu, Faming Jiang, Li Guo, et al.
Frontiers in Cellular and Infection Microbiology|February 16, 2026
Bovine leukemia virus: an emerging concern for zoonotic cross-species transmissionChangqing Yu, Yujing Li, Haojie Wang, et al.
Pageof 4